Form 4 for CDIO Cardio Diagnostics Holdings, Inc.
Accepted 2022-10-27 00:00:00 ET · period of report 2022-10-25 · accession 0001079973-22-001363 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-27 | 2022-10-25 | CDIO | Mana Capital LLC | 10% | J - Other | — | -1.56M | 0 | -100% | — |
| D | 2022-10-27 | 2022-10-25 | CDIO | Mana Capital LLC | 10% | J - Other | — | -2.50M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2022-10-25 | J | D | 1,565,000 | — | 0 | D | — | — | (F1) Pursuant to the terms of the Subscription Agreement and the Second Amended and Restated Subscription Agreement and Letter Agreement between the Reporting Person and the Issuer (the "Agreements"), the Reporting Person transferred all of the common stock and private warrants it acquired in connection with the Issuer's initial public offering to permitted transferees with no consideration in compliance with the Agreements. |
| 2 | Derivative | Private Warrant | 2022-10-25 | J | D | 2,500,000 | — | 0 | D | $11.50 · 2022-11-25 to 2027-10-25 | 2,500,000 Common Stock | (F1) Pursuant to the terms of the Subscription Agreement and the Second Amended and Restated Subscription Agreement and Letter Agreement between the Reporting Person and the Issuer (the "Agreements"), the Reporting Person transferred all of the common stock and private warrants it acquired in connection with the Issuer's initial public offering to permitted transferees with no consideration in compliance with the Agreements. |